Proangiogenic capacity of S100A4 in vivo and its influence on endothelial cells' motility in vitro was the first indication of the extracellular significance of S100A4 in tumour progression (Ambartsumian et al, 2001). The gene discussed is S100A4; the disease is neoplasm.